Absalom S R, Saverymuttu S H, Maxwell J D, Levin G E
Department of Chemical Pathology, St. George's Hospital Medical School, London, U.K.
Dig Dis Sci. 1988 May;33(5):565-9. doi: 10.1007/BF01798358.
We have compared the [14C]triolein breath test for fat malabsorption with fecal fat excretion corrected for marker pellet recovery in 23 subjects with chronic liver disease. The breath test identified 15 of the 17 subjects with abnormal fecal fat excretion (sensitivity 88%). However, four of the six subjects with normal fecal fat excretion gave abnormal breath test results (specificity 33%). While three of the four subjects with falsely abnormal breath tests had alcoholic liver disease, the explanation for the low specificity is unclear and may not be confined to patients with alcohol-related disease. We are therefore unable to recommend the breath test as a screen for steatorrhea in patients with chronic liver disease.
我们在23例慢性肝病患者中,比较了用于检测脂肪吸收不良的[14C]三油酸甘油酯呼气试验与校正标记药丸回收率后的粪便脂肪排泄情况。呼气试验在17例粪便脂肪排泄异常的患者中识别出15例(敏感性88%)。然而,6例粪便脂肪排泄正常的患者中有4例呼气试验结果异常(特异性33%)。虽然4例呼气试验结果假阳性的患者中有3例患有酒精性肝病,但特异性较低的原因尚不清楚,可能并不局限于酒精相关疾病患者。因此,我们无法推荐将呼气试验作为慢性肝病患者脂肪泻的筛查方法。